1 INTRODUCTION

1.1 MARKET DEFINITION

1.2 MARKET SEGMENTATION

1.3 RESEARCH TIMELINES

1.4 ASSUMPTIONS

1.5 LIMITATIONS
2 RESEARCH METHODOLOGY

2.1 DATA MINING

2.2 SECONDARY RESEARCH

2.3 PRIMARY RESEARCH

2.4 SUBJECT MATTER EXPERT ADVICE

2.5 QUALITY CHECK

2.6 FINAL REVIEW

2.7 DATA TRIANGULATION

2.8 BOTTOM-UP APPROACH

2.9 TOP-DOWN APPROACH

2.10 RESEARCH FLOW
3 EXECUTIVE SUMMARY

3.1 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET OVERVIEW

3.2 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ESTIMATES AND FORECAST (USD MILLION), 2021-2030

3.3 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET VALUE (USD MILLION) ESTIMATES AND FORECAST, 2021-2030

3.4 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES ECOLOGY MAPPING (% SHARE IN 2022)

3.5 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM

3.6 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ABSOLUTE MARKET OPPORTUNITY

3.7 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ATTRACTIVENESS ANALYSIS, BY REGION

3.8 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ATTRACTIVENESS ANALYSIS, BY TYPE

3.9 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION

3.10 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE (USD MILLION)

3.11 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION (USD MILLION)

3.12 FUTURE MARKET OPPORTUNITIES
4 MARKET OUTLOOK
4.1 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET EVOLUTION
4.2 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET OUTLOOK
4.3 MARKET DRIVERS

4.3.1 SURGE IN THE MARKET DEMAND FOR BIOSIMILARS AND BIOPHARMACEUTICAL PRODUCTS.

4.3.1 PRICING BENEFITS ASSOCIATED WITH OUTSOURCING SERVICES.

4.3.2 DATA SECURITY CONCERNS

4.3.3 REGULATORY COMPLIANCE CHALLENGES
4.4 MARKET TRENDS

4.4.1 RISING ACQUISITIONS, STRATEGIC PARTNERSHIPS AND COLLABORATIONS
4.5 MARKET OPPORTUNITY

4.5.1 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURES
4.6 PORTER’S FIVE FORCES ANALYSIS

4.6.1 THREAT OF NEW ENTRANTS

4.6.2 THREAT OF SUBSTITUTES

4.6.3 BARGAINING POWER OF SUPPLIERS

4.6.4 BARGAINING POWER OF BUYERS

4.6.5 INTENSITY OF COMPETITIVE RIVALRY
4.7 PRODUCT LIFELINE
4.8 CLINICAL TRIALS ANALYSIS

4.8.1 CLINICAL TRIALS IMPACT ANALYSIS
5 MARKET, BY TYPE

5.1 OVERVIEW

5.2 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY TYPE

5.3 CELL AND GENE THERAPY

5.4 IN-PROCESS AND PRODUCT RELEASE TESTING

5.5 FINISHED PHARMACEUTICAL PRODUCTS TESTING

5.6 ENVIRONMENTAL SAMPLES

5.7 OTHER
6 MARKET, BY APPLICATION

6.1 OVERVIEW

6.2 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION

6.3 ANALYTICAL TESTING

6.4 METHOD DEVELOPMENT

6.5 STABILITY TESTING

6.6 OTHER TESTING
7 MARKET, BY GEOGRAPHY

7.1 OVERVIEW

7.1.1 WEST

7.1.2 NORTHEAST

7.1.3 SOUTHEAST

7.1.4 MIDWEST

7.1.5 SOUTHWEST
8 COMPETITIVE LANDSCAPE

8.1 OVERVIEW

8.2 COMPETITIVE SCENARIO

8.3 COMPANY MARKET RANKING ANALYSIS

8.4 COMPANY INDUSTRY FOOTPRINT

8.5 ACE MATRIX

8.5.1 ACTIVE

8.5.2 CUTTING EDGE

8.5.3 EMERGING

8.5.4 INNOVATORS
9 COMPANY PROFILES
9.1 PPD, INC. (THERMO FISHER SCIENTIFIC)

9.1.1 COMPANY OVERVIEW

9.1.2 COMPANY INSIGHTS

9.1.3 SEGMENT BREAKDOWN

9.1.4 KEY DEVELOPMENT

9.1.5 PRODUCT BENCHMARKING

9.1.6 SWOT ANALYSIS

9.1.7 WINNING IMPERATIVES

9.1.8 CURRENT FOCUS & STRATEGIES

9.1.9 THREAT FROM COMPETITION
9.2 MILLIPORESIGMA (MERCK)

9.2.1 COMPANY OVERVIEW

9.2.2 COMPANY INSIGHTS

9.2.3 SEGMENT BREAKDOWN

9.2.4 PRODUCT BENCHMARKING

9.2.5 KEY DEVELOPMENT

9.2.6 SWOT ANALYSIS

9.2.7 WINNING IMPERATIVES

9.2.8 CURRENT FOCUS & STRATEGIES

9.2.9 THREAT FROM COMPETITION
9.3 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)

9.3.1 COMPANY OVERVIEW

9.3.2 COMPANY INSIGHTS

9.3.3 SEGMENT BREAKDOWN

9.3.4 PRODUCT BENCHMARKING

9.3.5 KEY DEVELOPMENT

9.3.6 SWOT ANALYSIS

9.3.7 WINNING IMPERATIVES

9.3.8 CURRENT FOCUS & STRATEGIES

9.3.9 THREAT FROM COMPETITION
9.4 EUROFINS SCIENTIFIC

9.4.1 COMPANY OVERVIEW

9.4.2 COMPANY INSIGHTS

9.4.3 SEGMENT BREAKDOWN

9.4.4 PRODUCT BENCHMARKING

9.4.5 KEY DEVELOPMENT

9.4.6 SWOT ANALYSIS

9.4.7 WINNING IMPERATIVES

9.4.8 CURRENT FOCUS & STRATEGIES

9.4.9 THREAT FROM COMPETITION
9.5 WUXI APPTEC

9.5.1 COMPANY OVERVIEW

9.5.2 COMPANY INSIGHTS

9.5.3 SEGMENT BREAKDOWN

9.5.4 PRODUCT BENCHMARKING

9.5.5 KEY DEVELOPMENT

9.5.6 SWOT ANALYSIS

9.5.7 WINNING IMPERATIVES

9.5.8 CURRENT FOCUS & STRATEGIES

9.5.9 THREAT FROM COMPETITION
9.6 SGS S.A.

9.6.1 COMPANY OVERVIEW

9.6.2 COMPANY INSIGHTS

9.6.3 SEGMENT BREAKDOWN

9.6.4 PRODUCT BENCHMARKING

9.6.5 KEY DEVELOPMENT

9.6.6 SWOT ANALYSIS

9.6.7 WINNING IMPERATIVES

9.6.8 CURRENT FOCUS & STRATEGIES

9.6.9 THREAT FROM COMPETITION
9.7 ALS LIMITED

9.7.1 COMPANY OVERVIEW

9.7.2 COMPANY INSIGHTS

9.7.3 SEGMENT BREAKDOWN

9.7.4 PRODUCT BENCHMARKING

9.7.5 KEY DEVELOPMENT

9.7.6 SWOT ANALYSIS

9.7.7 WINNING IMPERATIVES

9.7.8 CURRENT FOCUS & STRATEGIES

9.7.9 THREAT FROM COMPETITION
9.8 INTERTEK

9.8.1 COMPANY OVERVIEW

9.8.2 COMPANY INSIGHTS

9.8.3 SEGMENT BREAKDOWN

9.8.4 PRODUCT BENCHMARKING

9.8.5 KEY DEVELOPMENT

9.8.6 SWOT ANALYSIS

9.8.7 WINNING IMPERATIVES

9.8.8 CURRENT FOCUS & STRATEGIES

9.8.9 THREAT FROM COMPETITION
9.9 CHARLES RIVER LABORATORIES INTERNATIONAL INC.

9.9.1 COMPANY OVERVIEW

9.9.2 COMPANY INSIGHTS

9.9.3 SEGMENT BREAKDOWN

9.9.4 PRODUCT BENCHMARKING

9.9.5 KEY DEVELOPMENT

9.9.6 SWOT ANALYSIS

9.9.7 WINNING IMPERATIVES

9.9.8 CURRENT FOCUS & STRATEGIES

9.9.9 THREAT FROM COMPETITION
9.10 PACE ANALYTICAL SERVICES, LLC

9.10.1 COMPANY OVERVIEW

9.10.2 COMPANY INSIGHTS

9.10.3 SEGMENT BREAKDOWN

9.10.4 PRODUCT BENCHMARKING

9.10.5 KEY DEVELOPMENT

9.10.6 SWOT ANALYSIS

9.10.7 WINNING IMPERATIVES

9.10.8 CURRENT FOCUS & STRATEGIES

9.10.9 THREAT FROM COMPETITION
9.11 CATALENT, INC.

9.11.1 COMPANY OVERVIEW

9.11.2 COMPANY INSIGHTS

9.11.3 SEGMENT BREAKDOWN

9.11.4 PRODUCT BENCHMARKING

9.11.5 KEY DEVELOPMENT

9.11.6 SWOT ANALYSIS

9.11.7 WINNING IMPERATIVES

9.11.8 CURRENT FOCUS & STRATEGIES

9.11.9 THREAT FROM COMPETITION
9.12 ELEMENT MATERIALS TECHNOLOGY

9.12.1 COMPANY OVERVIEW

9.12.2 COMPANY INSIGHTS

9.12.3 SEGMENT BREAKDOWN

9.12.4 PRODUCT BENCHMARKING

9.12.5 KEY DEVELOPMENT

9.12.6 SWOT ANALYSIS

9.12.7 WINNING IMPERATIVES

9.12.8 CURRENT FOCUS & STRATEGIES

9.12.9 THREAT FROM COMPETITION
LIST OF TABLES

TABLE 1 FDA-APPROVED BIOSIMILAR PRODUCTS_2020 T0 2023

TABLE 2 CLINICAL TRIALS ANALYSIS

TABLE 3 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 5 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)

TABLE 6 WEST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 7 WEST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 8 NORTHEAST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 9 NORTHEAST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 10 SOUTHEAST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 11 SOUTHEAST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 12 MIDWEST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 MIDWEST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 14 SOUTHWEST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 15 SOUTHWEST PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 16 COMPANY INDUSTRY FOOTPRINT

TABLE 17 PPD, INC. (THERMO FISHER SCIENTIFIC): PRODUCT BENCHMARKING

TABLE 18 PPD, INC. (THERMO FISHER SCIENTIFIC): WINNING IMPERATIVES

TABLE 19 MILLIPORE SIGMA (MERCK): PRODUCT BENCHMARKING

TABLE 20 MILLIPORESIGMA (MERCK): KEY DEVELOPMENT

TABLE 21 MILLIPORESIGMA (MERCK): WINNING IMPERATIVES

TABLE 22 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP): PRODUCT BENCHMARKING

TABLE 23 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP): KEY DEVELOPMENT

TABLE 24 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP): WINNING IMPERATIVES

TABLE 25 EUROFINS SCIENTIFIC: PRODUCT BENCHMARKING

TABLE 26 EUROFINS SCIENTIFIC: KEY DEVELOPMENT

TABLE 27 EUROFINS SCIENTIFIC: WINNING IMPERATIVES

TABLE 28 WUXI APPTEC: PRODUCT BENCHMARKING

TABLE 29 WUXI APPTEC: KEY DEVELOPMENT

TABLE 30 WUXI APPTEC: WINNING IMPERATIVES

TABLE 31 SGS S.A.: PRODUCT BENCHMARKING

TABLE 32 SGS S.A.: KEY DEVELOPMENT

TABLE 33 ALS LIMITED: PRODUCT BENCHMARKING

TABLE 34 INTERTEK: PRODUCT BENCHMARKING

TABLE 35 CHARLES RIVER LABORATORIES INTERNATIONAL INC.: PRODUCT BENCHMARKING

TABLE 36 CHARLES RIVER LABORATORIES INTERNATIONAL INC.: KEY DEVELOPMENT

TABLE 37 PACE ANALYTICAL SERVICES, LLC: PRODUCT BENCHMARKING

TABLE 38 PACE ANALYTICAL SERVICES, LLC: KEY DEVELOPMENT

TABLE 39 CATALENT, INC.: PRODUCT BENCHMARKING

TABLE 40 CATALENT, INC.: KEY DEVELOPMENT

TABLE 41 ELEMENT MATERIALS TECHNOLOGY: PRODUCT BENCHMARKING

LIST OF FIGURES

FIGURE 1 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET SEGMENTATION

FIGURE 2 RESEARCH TIMELINES

FIGURE 3 DATA TRIANGULATION

FIGURE 4 MARKET RESEARCH FLOW

FIGURE 5 SUMMARY

FIGURE 6 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ESTIMATES AND FORECAST (USD MILLION), 2021-2030

FIGURE 7 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET VALUE (USD MILLION) AND ESTIMATES AND FORECAST, 2021-2030

FIGURE 8 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM

FIGURE 9 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ABSOLUTE MARKET OPPORTUNITY

FIGURE 10 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ATTRACTIVENESS ANALYSIS, BY REGION

FIGURE 11 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ATTRACTIVENESS ANALYSIS, BY TYPE

FIGURE 12 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION

FIGURE 13 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE (USD MILLION)

FIGURE 14 U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION (USD MILLION)

FIGURE 15 FUTURE MARKET OPPORTUNITIES

FIGURE 16 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET OUTLOOK

FIGURE 17 MARKET DRIVERS_IMPACT ANALYSIS

FIGURE 18 RESTRAINTS_IMPACT ANALYSIS

FIGURE 19 KEY TRENDS

FIGURE 20 PORTER’S FIVE FORCES ANALYSIS

FIGURE 21 PRODUCT LIFELINE: U.S. PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET

FIGURE 22 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY TYPE

FIGURE 23 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY TYPE

FIGURE 24 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY APPLICATION

FIGURE 25 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION

FIGURE 26 UNITED STATES PHARMACEUTICAL CONTRACT TESTING LABORATORIES MARKET, BY GEOGRAPHY, 2021-2030 (USD MILLION)

FIGURE 27 WEST MARKET SNAPSHOT

FIGURE 28 NORTHEAST MARKET SNAPSHOT

FIGURE 29 SOUTHEAST MARKET SNAPSHOT

FIGURE 30 MIDWEST MARKET SNAPSHOT

FIGURE 31 SOUTHWEST MARKET SNAPSHOT

FIGURE 32 KEY STRATEGIC DEVELOPMENTS

FIGURE 33 PPD, INC. (THERMO FISHER SCIENTIFIC): COMPANY INSIGHT

FIGURE 34 PPD, INC. (THERMO FISHER SCIENTIFIC): BREAKDOWN

FIGURE 35 PPD, INC. (THERMO FISHER SCIENTIFIC): SWOT ANALYSIS

FIGURE 36 MILLIPORESIGMA (MERCK): COMPANY INSIGHT

FIGURE 37 MILLIPORESIGMA (MERCK): BREAKDOWN

FIGURE 38 MILLIPORESIGMA (MERCK): SWOT ANALYSIS

FIGURE 39 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP): COMPANY INSIGHT

FIGURE 40 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP): BREAKDOWN

FIGURE 41 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP): SWOT ANALYSIS

FIGURE 42 EUROFINS SCIENTIFIC: COMPANY INSIGHT

FIGURE 43 EUROFINS SCIENTIFIC: BREAKDOWN

FIGURE 44 EUROFINS SCIENTIFIC: SWOT ANALYSIS

FIGURE 45 WUXI APPTEC: COMPANY INSIGHT

FIGURE 46 WUXI APPTEC: SEGMENT BREAKDOWN

FIGURE 47 WUXI APPTEC: SWOT ANALYSIS

FIGURE 48 SGS S.A.: COMPANY INSIGHT

FIGURE 49 SGS S.A.: BREAKDOWN

FIGURE 50 ALS LIMITED: COMPANY INSIGHT

FIGURE 51 ALS LIMITED: BREAKDOWN

FIGURE 52 INTERTEK: COMPANY INSIGHT

FIGURE 53 INTERTEK: BREAKDOWN

FIGURE 54 CHARLES RIVER LABORATORIES INTERNATIONAL INC.: COMPANY INSIGHT

FIGURE 55 CHARLES RIVER LABORATORIES INTERNATIONAL INC.: BREAKDOWN

FIGURE 56 PACE ANALYTICAL SERVICES, LLC: COMPANY INSIGHT

FIGURE 57 CATALENT, INC.: COMPANY INSIGHT

FIGURE 58 CATALENT, INC.: BREAKDOWN

FIGURE 59 ELEMENT MATERIALS TECHNOLOGY: COMPANY INSIGHT

The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures of the market/sub-segments in the current scenario as well as for the forecast period. 

After estimating the markets and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.

1.1 DATA MINING
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the industry and their Drivetrain, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
1.2 SECONDARY RESEARCH
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at TRI have access to some of the most diversified and extensive paid databases, which give us the most accurate data/information on markets Customers, and pricing. Mentioned below is a detailed list of sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data sources depending on the need.
1.3 PRIMARY RESEARCH
In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (Corporates), industry consultants, and C-Component executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below. 
1.4 FORCASTING TECHNIQUES
We at Markstats Research Insights Private Limited follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.